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ORIGINAL ARTICLE
Contrast media has been used in angiography
for more than 80 years.1 Low-osmolar and non-
ionic contrast media are safer in cardiac angio-
graphy with fewer hemodynamic changes and
lower incidence of malignant arrhythmias.2–5
Nephrotoxicity is still the major problem, and an
increase in serum creatinine of more than 1.5
mg/dL has been observed in 6% of patients
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Background/Purpose: Hemodynamic changes and contrast nephropathy are well known complications
of contrast media injection. However, the mechanisms of toxicity leading to these complications remain
unclear. We hypothesized that contrast media toxicity would manifest as a change in antioxidant enzyme
activity, thus leading to tissue damage.
Methods: This study investigated the effects of injection of ionic high-osmolar diatrizoate, ionic low-
osmolar ioxaglate, and nonionic low-osmolar iopromide on the activities of two antioxidant enzymes,
glutathione peroxidase (GPX) and superoxide dismutase (SOD), in the heart and kidney tissue of normal
male Wistar rats (n = 51) and streptozotocin (STZ)-induced diabetic rats (n = 54). Activities of GPX and
SOD were assayed spectrophotometrically.
Results: Renal GPX activities were significantly decreased in both normal (458.3 ± 64.6 to 385.5 ± 63.4
mU/mg, p = 0.005) and diabetic rats (669.0 ± 98.1 vs. 564.0 ± 153.3 mU/mg, p = 0.035) at 1 hour after dia-
trizoate injection. Renal SOD activities were not affected after contrast injection. Ioxaglate and iopromide
injection did not cause any change in renal antioxidant enzyme activity. In contrast to kidney tissue, there
was no significant change in GPX and SOD activities in heart tissue at 1 hour after injection of different
contrast media.
Conclusion: Intravenous injection of ionic high-osmolar diatrizoate reduced renal GPX activity during the
first hour in both normal and STZ-induced diabetic rats. Heart tissue was not prone to antioxidant enzyme
activity changes after intravenous contrast media injection. GPX activity reduction can be an impor ttan
mechanism of nephrotoxicity after contrast media injection. [J Formos Med Assoc 2006;105(7):530–535]
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using nonionic contrast media.6 Diabetes melli-
tus (DM) and preexisting renal insufficiency are
the major risk factors for contrast nephropathy.
The pathophysiology of contrast media nephropa-
thy is not well understood.7 Animal experiments
have shown that contrast nephropathy is ac-
companied by increased production of reactive
oxygen species.8 Other studies have shown that
administration of radiocontrast agents increase
lipid peroxidation in rat kidneys.9 This study as-
sessed the effects of intravenous injection of ionic
high-osmolar, ionic low-osmolar, and nonionic
low-osmolar contrast media on antioxidant en-
zyme activity in the heart and kidneys of normal
and streptozotocin (STZ)-induced diabetic rats.
Methods
Contrast media
The effects of the following three types of con-
trast media were studied: (1) ionic high-osmolar
diatrizoate meglumine/diatrizoate sodium (DTZ)
(Hypaque-75, Squibb, USA; osmolarity 2016
mOsm/kg, iodine content 370 mg/mL); (2) ionic
low-osmolar ioxaglate (IXG) (Hexabrix-320,
France; osmolarity 600 mOsm/kg, iodine content
320 mg/mL); and (3) nonionic low-osmolar io-
promide (IPM) (Ultravest-370, Schering, Germany;
osmolarity 880 mOsm/kg, iodine content 370
mg/mL).
Study animals
This study was approved by the Animal Care and
Treatment Committee of our institution. Male
Wistar rats (purchased from the National Labo-
ratory Animal Breeding and Research Center,
Taiwan), 6–8 weeks old and weighing 150–180 g
were used. DM was induced by a single peritoneal
injection of 55 mg/kg STZ (Sigma Chemical,
St Louis, MO, USA). Diabetes was confirmed by
checking blood glucose (Precision Plus, Abbott
Laboratories, IL, USA). With successful DM induc-
tion, blood glucose level was greater than 200
mg/dL within 24–36 hours after STZ injection. If
the rat’s blood glucose was below 200 mg/dL,
another dose of 55 mg/kg STZ was injected. The
blood glucose of diabetic rats was monitored
daily, and insulin (Monotard HM, Novo Nordisk,
Denmark) was injected subcutaneously to main-
tain a blood glucose level of around 350 mg/dL.
All were fed a regular diet and water until 4 weeks
rafter the day of STZ injection. All rats fasted fo
24 hours prior to the start of experiments.
Normal and STZ-induced diabetic rats were
rseparated into three different contrast media o
normal saline injection groups for injection with
ra volume of 10 mL/kg for DTZ, 11.6 mL/kg fo
IXG, 10 mL/kg for IPM and 10 mL/kg for normal
saline. Injections were administered via tail vein
puncture. One hour after injection, the rats were
tanesthetized with sodium pentobarbital (Abbot
Laboratories) and sacrificed for dissection. The
heart and kidneys were obtained for analysis.
Measurements of antioxidant enzyme
activities
The dissected kidney and heart tissue was imme-
diately rinsed in ice-cold phosphate-buffered
saline. Cleaned specimens were chipped and
homogenized in appropriate buffer solution,
which contained 50 mM Tris-HCl at pH 7.5, 5 mM
tEDTA and 1 mM 2-mercaptoethanol. Antioxidan
enzyme activities were determined by spectropho-
tometric assays. Glutathione peroxidase (GPX)
activity was assayed in a 1-cm path cuvette contain-
ing 350 μL assay buffer (GPx-340, OxisResearch,
LPortland, USA), 350 μL NADPH reagent and 70 μ
test sample that was prepared and diluted into
 assay buffer just prior to analysis. The mixture
in the cuvette was added to 350 μL diluted tert-
butyl hydroperoxide and then mixed. Absorbance
at 340 nm was recorded at 23°C for 3 minutes.
Superoxide dismutase (SOD) activity was meas-
ured with an assay kit (SOD-525, OxisResearch)
by the suggested procedure summarized as fol-
 lows: 30 μL sample was incubated in a 1-cm
optical path cuvette with 500 μL 10 mM hydrogen
peroxide for 1 minute and finally chromogen
reagent. The absorbance of samples was recorded
at 525 nm at 37°C. All activities of GPX and SOD
were normalized by correction of sample protein
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content. All measurements were repeated three
times with intra-variation less than 8%.
Statistical analysis
All values were expressed as mean ± standard de-
viation. Two-way ANOVA was performed to test
whether the DM/normal rats or contrast media/
normal saline affected the results of enzyme ac-
tivity. Statistical significance was analyzed using
the unpaired Student’s t test. A p value < 0.05 was
considered to be statistically significant.
Results
A total of 105 male Wistar rats were used. Fifty-four
STZ-induced DM rats had a mean body weight of
243.6±49.6 g, and the mean body weight of 51
normal rats was 314.0±49.9 g. The mean blood
glucose of diabetic rats was 379.6±83.3 mg/dL.
In the saline injection group, DM rats had
higher renal GPX activities than normal rats
(669.0 ± 98.1 vs. 458.3 ± 64.6 mU/mg, p < 0.0001).
In contrast to renal GPX, renal SOD activity tended
to be lower in DM than normal rats, but this differ-
ence was not significant (p = 0.264; Table 1). In
heart tissue, both GPX (456.5 ± 62.5 vs. 424.9 ±
63.5 U/mg) and SOD activities (306.8 ± 61.0 vs.
279.1 ± 66.0 U/mg) were higher in DM rats than
tin normal rats, although this difference was no
significant (p = 0.182 and 0.373) (Table 2).
DTZ, IXG and IPM injections were given to
14, 15 and 11 normal rats and 15, 15, 12 DM
rats, respectively. Renal GPX activity was signifi-
cantly lower in the DTZ group than in the saline
groups in both normal (458.3 ± 64.6 vs. 385.5 ±
63.4 mU/mg, p = 0.005) and STZ-induced DM
rats (669.0 ± 98.1 vs. 564.0 ± 153.3 mU/mg, p =
t0.035) (Figure). Renal GPX activities were no
significantly different among the IXG (449.2 ±
Table 1. Antioxidant enzymes in kidney tissue 1 hour after injection of various contrast media in normal and 
streptozotocin-induced DM rats*
Normal rats DM rats
n GPX (mU/mg) SOD (U/mg) n GPX (mU/mg) SOD (U/mg)
NS 11 458.3 ± 64.6 628.4 ± 106.4 12 669.0 ± 98.1 583.3 ± 109.7
DTZ 14 385.5 ± 63.4† 675.8 ± 148.3 15 564.0 ± 153.3‡ 635.1 ± 113.1
IXG 15 449.2 ± 94.7 642.6 ± 113.9 15 642.9 ± 99.0 602.7 ± 102.5
IPM 11 444.8 ± 68.0 571.5 ± 78.7 12 656.0 ± 125.0 575.6 ± 83.9
*All values of enzyme activity are presented as mean ± standard deviation; †GPX activity in DTZ group of normal rats was significantly lower than in 
NS group and p = 0.005; ‡GPX activity in DTZ group of DM rats was significantly lower than in NS group and p = 0.035. DM = diabetes mellitus; GPX =
glutathione peroxidase; SOD = superoxide dismutase; NS = normal saline; DTZ = diatrizoate; IXG = ioxaglate; IPM = iopromide.
Table 2. Antioxidant enzymes in heart tissue 1 hour after injection of various contrast media in normal and
streptozotocin-induced DM rats*
Normal rats DM rats
n GPX (mU/mg) SOD (U/mg) n GPX (mU/mg) SOD (U/mg)
NS 11 424.9 ± 63.5 279.1 ± 66.0 12 456.5 ± 62.5 306.8 ± 61.0
DTZ 14 428.4 ± 69.5 271.0 ± 57.4 15 460.1 ± 69.4 310.6 ± 73.0
IXG 15 433.3 ± 67.3 267.1 ± 78.7 15 458.0 ± 84.1 280.0 ± 62.9
IPM 11 460.1 ± 104.1 304.1 ± 102.3 12 464.1 ± 74.3 299.0 ± 86.2
*All values of enzyme activity are presented as mean ± standard deviation. DM = diabetes mellitus; GPX = glutathione peroxidase; SOD = superoxide dismu-
tase; NS = normal saline; DTZ = diatrizoate; IXG = ioxaglate; IPM = iopromide.
94.7 mU/mg), IPM (444.8 ± 68 mU/mg) and
saline control groups (Table 1). Renal SOD ac-
tivities are also listed in Table 1. There was no
significant difference in SOD activities among
the three contrast media groups, both in normal
and DM rats. GPX and SOD activities in heart 
tissue were not significantly different among
contrast media groups, both in normal and
DM rats.
Discussion
This study demonstrated that injection of ionic,
high-osmolar contrast media diatrizoate reduced
renal GPX activity in both normal Wistar and
STZ-induced DM rats. Ionic low-osmolar ioxaglate
and nonionic low-osmolar iopromide, however,
did not have a significant effect on renal GPX 
activity. Ionic high-osmolar contrast media has
been shown to cause more advanced and pro-
longed renal function depression than nonionic
low-osmolar contrast media in patients with nor-
mal renal function and in patients with preexist-
ing renal dysfunction.10,11 While experimental and
laboratory studies have suggested that ionic high-
osmolar contrast media have the greatest nephro-
toxic potential, this study demonstrated that GPX
tactivity was reduced by high-osmolar contras
media injection.
Antioxidant enzymes serve as a defense
mechanism against reactive oxygen species. In
rthe kidney, proximal tubular cells and, to a lesse
cextent, glomeruli show activities of copper, zin
and manganese SOD, catalase and GPX.12 SOD
forms H2O2 out of O2−•, which can then be con-
verted to H2O and O2 by the catalase system.
Additional H2O2 can be detoxified by peroxi-
dases, mainly by GPX.13 tAmong the antioxidan
tenzymes, GPX has been reported to be the mos
clearly influenced by lifestyle and environmental
factors, such as intake of dietary supplements
and smoking behavior.14 A clinical study showed
that a decrease in plasma GPX activity was asso-
ciated with progression of renal disorders.15 An
animal study showed that GPX-deficient mice
had increased oxidative stress, impaired endo-
thelial function and structural vascular abnor-
malities.16 In this study, renal SOD activity did
not change significantly after contrast media in-
jection in both normal and DM rats. This sug-
gests that reduction of GPX rather than SOD was
involved in the mechanism of contrast nephro-
 pathy. Reduction of renal GPX after the injection
of high-osmolar contrast media may cause an
imbalance between the availability of the defense
mechanism and the presence of reactive oxygen
species, thus resulting in oxidative stress-induced
Xglomerular injury. In addition, more severe GP
depletion may serve as a contributory factor to
contrast-induced renal vasoconstriction.
Unlike the kidneys, GPX and SOD activity in the
heart tissue of normal and DM rats were not signifi-
cantly different between groups of rats treated with
fcontrast media or normal saline. The activity o
tantioxidant enzymes is variable within differen
tissues and cell types.12 Therefore, different organs
and tissues have different susceptibilities to reac-
tive oxygen species. Another factor associated
with the extent of tissue injury is the exposure
concentration and time. With intravenous injec-
tion in humans, arterial enhancement decays al-
most within 30 seconds as each heart beat dilutes
fthe contrast medium. In first pass dynamics o
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pharmacokinetics, if more blood is ejected per
unit of time, the contrast medium injected per
unit of time will be diluted.17,18 The majority of
contrast media is excreted unmetabolized via the
kidney. Contrast media are small molecules and
are filtrated freely through the basal membrane
of renal glomeruli. They are concentrated 100
times in the urine. Consequently, the osmotic
load of contrast media that is presented to the
kidney tubules during the first hour after injec-
tion is very high.19 Due to the different exposure
conditions to contrast media in vivo, the response
of antioxidant enzymes in the heart cannot be the
same as in the kidneys after intravenous contrast
media injection.
Glomerular expression of antioxidant en-
zymes can be modulated. In this study, renal GPX
activity in DM rats was 46% higher than in nor-
mal rats. Diabetes is characterized by high glucose
concentrations that lead, via several mechanisms,
to increased oxidative stress.20,21 Animal studies
have shown high renal activities of GPX and de-
creased renal catalase and SOD in STZ-induced
DM compared to controls.12,22 Our findings are
consistent with these studies.
In a previous experiment, we found that serum
creatinine levels were within normal limits in both
normal and DM rats and were not significantly
different. There was also no significant change in
serum creatinine level 1 hour after contrast media
injection. Clinically, contrast nephropathy gener-
ally presents as a rise in serum creatinine 24–48
hours after contrast exposure, peaking within 3–5
days.23 Our results suggest that change in anti-
oxidant enzyme activity, such as GPX activity 
reduction in renal tissue, which occurs in the 
first hour after administration, is a rapid response
to contrast media exposure and precedes the 
detectable rise of serum creatinine.
Previous studies have demonstrated the pres-
ence of complex alterations in the activities of
antioxidant enzymes in various tissues of STZ-
induced DM rats.22 In this study, antioxidant en-
zymes in heart tissue were not different between
normal and DM rats. This implies that antioxi-
dant enzyme alteration did not develop during 
4 weeks of hyperglycemic status. A longer period
of hyperglycemia would be needed to cause
fsignificant oxidative stress in the heart tissue o
STZ-induced DM rats.
The patterns of antioxidant enzyme alterations
in chemically-induced DM are independent of the
diabetogenic agent used. In addition, comparative
studies involving red blood cells from DM rats
and human diabetics revealed a number of com-
mon changes.22 Our results showing Xrenal GP
ractivity reduction in rats may reflect a simila
change in human beings, and represent an impor-
tant mechanism of renal function deterioration
after contrast media injection, especially when
ionic high-osmolar contrast media are used.
fThe relatively high analytical variation o
SOD and GPX in this study is probably attributa-
ble to unavoidable differences in manual weigh-
ing and pipetting of reagents as well as to small
variations between kits.
cIn conclusion, intravenous injection of ioni
high-osmolar diatrizoate reduced renal GPX ac-
tivity during the first hour in both normal and
rSTZ-induced DM rats. Neither ionic low-osmola
ioxaglate nor nonionic low-osmolar iopromide
injection changed renal GPX or SOD activities.
The heart tissue of normal and DM rats were
not prone to antioxidant enzyme activity changes
after intravenous contrast media injection. These
results suggest that GPX activity reduction is an
important mechanism of contrast media-induced
nephrotoxicity, especially that which occurs when
using ionic high-osmolar contrast media.
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